HLA-C and graft versus host disease: In contrast to severe GvHD in NSG mice, GvHD associated symptoms were totally absent in NSG-MHC-KO mice and no survival differences were observed between CAR T cell cohorts with or without PEN-221 treatment (Fig. 3g).